| Author (Corporate) | European Commission: DG Communication |
|---|---|
| Series Title | Press Release |
| Series Details | IP/07/1298 (11.9.07) |
| Publication Date | 11/09/2007 |
| Content Type | News |
|
Preliminary results of the first clinical trial of a novel avian H7N1 influenza ("bird flu") vaccine have shown that it is safe and well tolerated in healthy volunteers. The vaccine was developed, from the design of the vaccine virus to the completion of this first clinical trial, by a team of European scientists and co-funded by the EU Research Framework Programme. The European Commission also announced today the results of its latest call for proposals for new influenza research projects: With more than €27 million for 11 new collaborative projects the Commission continues its longstanding support for innovative scientific solutions in the fight against this deadly disease. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/07/1298&format=HTML&aged=0&language=EN&guiLanguage=en |
| Related Links |
|
| Subject Categories | Culture, Education and Research |
| Countries / Regions | Europe |
